Undisclosed Tau Immunotherapy
Tau-related Frontotemporal Dementia (FTD-tau)
Key Facts
About TauC3 Biologics
TauC3 Biologics is a private, preclinical-stage biotech developing novel antibody-based therapies targeting pathological tau in neurodegenerative diseases. The company is assembling a leadership team with deep expertise in neuroscience drug development, finance, and business strategy. Its mission is to address the high unmet medical need in tauopathies like FTD and PSP, which currently lack disease-modifying treatments.
View full company profileAbout TauC3 Biologics
TauC3 Biologics is a private, preclinical-stage biotech developing novel antibody-based therapies targeting pathological tau in neurodegenerative diseases. The company is assembling a leadership team with deep expertise in neuroscience drug development, finance, and business strategy. Its mission is to address the high unmet medical need in tauopathies like FTD and PSP, which currently lack disease-modifying treatments.
View full company profile